Invesco Ltd.

Position in DNTH — Dianthus Therapeutics, Inc. /DE/

CIK 914208 Atlanta, GA

Position in DNTH

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$8,344,579

-$2,627,707 QoQ

Shares Held

85,603

-34.5% QoQ

Ownership

0.153%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#87

of 269 holders

Holding Since

Jun 2021

13 quarters on record

Voting authority Sole 0% Shared 99% None 1%

Healthcare · as of Jun 30, 2026

Invesco Ltd. holds $14,221,834,024 across 296 Biotechnology names. DNTH ranks #59 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	8,043,052	$3,995,225,212
2	REGN	Regeneron Pharmaceuticals, Inc.	3,940,665	$2,457,162,245
3	ALNY	Alnylam Pharmaceuticals, Inc.	3,754,318	$1,130,162,341
4	INCY	Incyte Corp	4,080,461	$462,561,050
5	ARGX	Argenx SE	443,990	$411,920,598
6	AXSM	Axsome Therapeutics, Inc.	1,671,684	$409,178,086
7	MRNA	Moderna, Inc.	5,780,299	$404,794,337
8	LGND	Ligand Pharmaceuticals Inc	1,201,644	$379,827,645

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$8,344,579	85,603	-34.5%	Shares	Defined	2026-08-14
2026-03-31	$10,972,286	130,747	+28.8%	Shares	Defined	2026-05-12
2025-12-31	$4,182,360	101,489	+125.9%	Shares	Defined	2026-02-19
2025-09-30	$1,767,955	44,929	+114.6%	Shares	Defined	2025-11-13
2025-06-30	$390,111	20,940	+31.1%	Shares	Defined	2025-08-13
2025-03-31	$289,839	15,978	+38.7%	Shares	Defined	2025-05-12
2024-12-31	$251,156	11,521	+7.4%	Shares	Defined	2025-02-13
2024-09-30	$293,812	10,731	-3.6%	Shares	Defined	2024-11-12
2024-06-30	$288,172	11,135	—	Shares	Defined	2024-08-13
2022-03-31 MGTA	—	11,334	+2.0%	Shares	Defined	2022-05-16
2021-12-31 MGTA	—	11,107	-14.3%	Shares	Defined	2022-02-14
2021-09-30 MGTA	—	12,964	+18.3%	Shares	Defined	2021-11-15
2021-06-30 MGTA	—	10,959	—	Shares	Defined	2021-08-17
No filing history on record for this holder in this stock.